Country Report / New Hungary Pharma Report 2020 Out Now
In line with its status as one of Europe’s most dynamic economies, Hungary is aiming to boost both its life sciences industry and the level of healthcare it provides to…
Address: Zolyomi ut 23 H-1118 Budapest,Hungary
Tel: +36 1 391 4455
Abiomics Europe Ltd.
„Advanced Biostatistics and Intelligence for the Omics”
Abiomics Europe Ltd. is a technology startup company that was founded in 2009 by bioinformatics and biomedical researchers along with investors. The cooperation between the Semmelweis University, Department of Genetics, Cell- and Immunobiology and the Budapest University of Technology and Economics, Department of Measurement and Information Systems started in 2005 and led to the establishment of the company.
The 5 years of cooperation and joint projects made it clear that modern life science research and development is not possible anymore without advanced information technology support. The GenaGrid consortium was founded in 2008 with the support of the National Office for Research and Technology when new academic and industry partners joined the research group and aims to develop various bioinformatics services. Abiomics Europe Ltd. is the company responsible for the utilization for the intellectual properties of the consortium and has all the exclusive rights for the developed technologies. Abiomics Europe drives the business development, market research and marketing activities for the consortium.
The GenaGrid research group and Abiomics Europe employs almost 30 informaticians and biomedical researchers. The group engages the technologies and software in Asthma and ALL research. The GenaGrid research group operates a genomics lab and the most powerful grid supercomputer dedicated for life science research in Hungary with 512 CPUs (March 2010).
Abiomics provides to their customers advanced information technology support.
In line with its status as one of Europe’s most dynamic economies, Hungary is aiming to boost both its life sciences industry and the level of healthcare it provides to…
Hungary’s longstanding tradition of pharmacology is a major point of pride for the country’s scientists and researchers who today have hopes to elevate the country’s research environment to a region-leading…
According to Peter Holchacker, director general of Hungary’s Association of Innovative Pharmaceutical Manufacturers (AIPM), “clinical trials initiated by multinational companies, represent, on average, an investment of approximately EUR 300 million…
Established in 1997, Medi-Radiopharma is a Hungarian privately held company operating in the field of nuclear medicine, a specialized area of radiology that uses very small amounts of radioactive materials,…
As general manager of the Hungarian affiliate of Swiss firm IBSA, Anna Wienner has proven herself to be a motivated pharma leader with particular expertise in reshaping and building organizations.…
Krisztina Kárpát, MD of Bayer Hungary, elaborates on the successful development of the affiliate in recent years, making progress in all three business units of pharma, consumer health, and crop…
Judit Bidlo, deputy director general of price support at the Hungarian National Health Insurance (NEAK), shares her insights on the healthcare system’s developments over the last three years, the rationale…
Among the efforts of Hungarian stakeholders to determine more efficient pricing and reimbursement structures, there is a common ambition to explore what is considered by many to be the next…
In 2016, Hungary transitioned from a second-tier member to a full member of the EU. As Judit Bidló, deputy director general of pricing and reimbursement for Hungary’s National Institute of…
Tamás Demeter, Country Manager for AOP Orphan shares his insights on the footprint of the company in Hungary, the areas of therapeutic need that AOP caters to, the performance of…
Katinka Zinnemers, managing director of Abacus Medicine, highlights the company’s mission to increase access to medicines for all patients and its commitment to building trust with authorities as it enters…
Csaba Kis, CEO of Qualiskills, shares his insights on the packaging capabilities of the company, its sustainable competitive advantage, the impact of the European serialization guidelines, and the company’s strategic…
See our Cookie Privacy Policy Here